Bruce D Schultz

Title: Innovator Profile: Bruce D Schultz and His Groundbreaking Contributions

Introduction

Bruce D Schultz, an accomplished inventor based in Wamego, Kansas, has made significant contributions to the field of biochemistry with a focus on peptide innovation. With a total of three patents to his name, Schultz is well-regarded for his research and development of peptides that exhibit groundbreaking functionalities.

Latest Patents

Schultz's latest inventions include an innovative class of channel forming peptides based on the M2GlyR sequence. These peptides are unique derivatives that can be tailored at their ends to incorporate several polar amino acid residues, enhancing their solubility. Notably, the peptides feature palindromic portions of the M2GlyR sequence, ensuring they retain efficacy at lower concentrations. Research has demonstrated that these peptides can markedly increase transepithelial electrical resistance in cells, exhibiting half-maximal effects at or below 30 µM, which represents a substantial advancement over prior M2GlyR family peptides. Furthermore, these peptides also modulate the permeability of tight junctions in epithelial cells, showcasing their potential applications in biomedical research.

Career Highlights

Throughout his career, Bruce D Schultz has collaborated with esteemed institutions, including the Kansas State University Research Foundation and Eli Lilly and Company. His research endeavors within these organizations have facilitated his exploration of peptide sequences and their functional applications, contributing to his overall patent portfolio.

Collaborations

During his tenure at various institutions, Schultz has collaborated with notable professionals, including John M Tomich and James R Broughman. These partnerships have not only enriched his research but have also fostered an environment of innovation and shared knowledge in the field of peptide research.

Conclusion

In summary, Bruce D Schultz stands out as an innovative inventor whose work with M2GlyR derived peptides positions him at the forefront of biochemistry and pharmaceutical research. His contributions continue to pave the way for new discoveries and applications in the realm of peptide functionality and beyond.